<!DOCTYPE html> <html lang="en"> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"> <meta name="google-site-verification" content="Pj4WWF5m9cqCcPqkGG75BI1_593zXImuFRpI8TnAous"> <meta http-equiv="Permissions-Policy" content="interest-cohort=()"> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <title> t-cell dynamics matter | Masahiro Ono </title> <meta name="author" content="Masahiro Ono"> <meta name="description" content="lessons from the first treg immunotherapy trial"> <meta name="keywords" content="jekyll, jekyll-theme, academic-website, portfolio-website"> <meta property="og:site_name" content="Masahiro Ono"> <meta property="og:type" content="article"> <meta property="og:title" content="Masahiro Ono | t-cell dynamics matter"> <meta property="og:url" content="https://monotockylab.github.io/blog/2024/TGN1412/"> <meta property="og:description" content="lessons from the first treg immunotherapy trial"> <meta property="og:image" content="https://monotockylab.github.io/assets/img/tocky/socialmediapreview.png"> <meta property="og:image:url" content="https://monotockylab.github.io/assets/img/tocky/socialmediapreview.png"> <meta property="og:image:secure_url" content="https://monotockylab.github.io/assets/img/tocky/socialmediapreview.png"> <meta property="og:locale" content="en"> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="@MonoTockyLab"> <meta name="twitter:creator" content="@MonoTockyLab"> <meta name="twitter:title" content="Masahiro Ono | t-cell dynamics matter"> <meta name="twitter:description" content="lessons from the first treg immunotherapy trial"> <meta name="twitter:image" content="https://monotockylab.github.io/assets/img/tocky/socialmediapreview.png"> <link rel="stylesheet" href="/assets/css/bootstrap.min.css?a4b3f509e79c54a512b890d73235ef04"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/css/mdb.min.css" integrity="sha256-jpjYvU3G3N6nrrBwXJoVEYI/0zw8htfFnhT9ljN3JJw=" crossorigin="anonymous"> <link defer rel="stylesheet" href="/assets/css/academicons.min.css?f0b7046b84e425c55f3463ac249818f5"> <link defer rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700|Roboto+Slab:100,300,400,500,700|Material+Icons&amp;display=swap"> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-github.css?591dab5a4e56573bf4ef7fd332894c99" media="" id="highlight_theme_light"> <link rel="shortcut icon" href="/assets/img/favicon.png?fdf6bb598ff65151e77547fe2c57a41a"> <link rel="stylesheet" href="/assets/css/main.css?d41d8cd98f00b204e9800998ecf8427e"> <link rel="canonical" href="https://monotockylab.github.io/blog/2024/TGN1412/"> <script src="/assets/js/theme.js?a5ca4084d3b81624bcfa01156dae2b8e"></script> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-native.css?5847e5ed4a4568527aa6cfab446049ca" media="none" id="highlight_theme_dark"> <script>initTheme();</script> <link defer rel="stylesheet" href="https://cdn.jsdelivr.net/npm/img-comparison-slider@8.0.6/dist/styles.min.css"> <link defer rel="stylesheet" href="https://cdn.jsdelivr.net/npm/swiper@11.0.5/swiper-bundle.min.css" integrity="sha256-yUoNxsvX+Vo8Trj3lZ/Y5ZBf8HlBFsB6Xwm7rH75/9E=" crossorigin="anonymous"> </head> <body class="fixed-top-nav "> <header> <nav id="navbar" class="navbar navbar-light navbar-expand-sm fixed-top" role="navigation"> <div class="container"> <a class="navbar-brand title font-weight-lighter" href="/"> Masahiro Ono </a> <button class="navbar-toggler collapsed ml-auto" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar top-bar"></span> <span class="icon-bar middle-bar"></span> <span class="icon-bar bottom-bar"></span> </button> <div class="collapse navbar-collapse text-right" id="navbarNav"> <ul class="navbar-nav ml-auto flex-nowrap"> <li class="nav-item "> <a class="nav-link" href="/">about </a> </li> <li class="nav-item "> <a class="nav-link" href="/blog/">blog </a> </li> <li class="nav-item "> <a class="nav-link" href="/publications/">publications </a> </li> <li class="nav-item "> <a class="nav-link" href="/research/">research </a> </li> <li class="nav-item "> <a class="nav-link" href="/cv/">cv </a> </li> <li class="nav-item "> <a class="nav-link" href="/researcher/">researcher </a> </li> <li class="nav-item dropdown "> <a class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">submenus </a> <div class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdown"> <a class="dropdown-item " href="/talks/">talks</a> <div class="dropdown-divider"></div> <a class="dropdown-item " href="/research/">research</a> <div class="dropdown-divider"></div> <a class="dropdown-item " href="/japanese/">日本語</a> <div class="dropdown-divider"></div> <a class="dropdown-item " href="/access/">access</a> </div> </li> <li class="toggle-container"> <button id="light-toggle" title="Change theme"> <i class="ti ti-sun-moon" id="light-toggle-system"></i> <i class="ti ti-moon-filled" id="light-toggle-dark"></i> <i class="ti ti-sun-filled" id="light-toggle-light"></i> </button> </li> </ul> </div> </div> </nav> <progress id="progress" value="0"> <div class="progress-container"> <span class="progress-bar"></span> </div> </progress> </header> <div class="container mt-5" role="main"> <div class="post"> <header class="post-header"> <h1 class="post-title">t-cell dynamics matter</h1> <p class="post-meta"> June 07, 2024 </p> <p class="post-tags"> <a href="/blog/2024"> <i class="fa-solid fa-calendar fa-sm"></i> 2024 </a>   ·   <a href="/blog/tag/self-reactivity"> <i class="fa-solid fa-hashtag fa-sm"></i> self-reactivity</a>   <a href="/blog/tag/t-cells"> <i class="fa-solid fa-hashtag fa-sm"></i> t-cells</a>   <a href="/blog/tag/treg"> <i class="fa-solid fa-hashtag fa-sm"></i> treg</a>   <a href="/blog/tag/tgn1412"> <i class="fa-solid fa-hashtag fa-sm"></i> tgn1412</a>   <a href="/blog/tag/immunotherapy"> <i class="fa-solid fa-hashtag fa-sm"></i> immunotherapy</a>     ·   <a href="/blog/category/blog"> <i class="fa-solid fa-tag fa-sm"></i> blog</a>   </p> </header> <article class="post-content"> <div id="markdown-content"> <img-comparison-slider> <figure slot="first"> <picture> <source class="responsive-img-srcset" srcset="/assets/img/tgn1412/tcellactivation-480.webp 480w,/assets/img/tgn1412/tcellactivation-800.webp 800w,/assets/img/tgn1412/tcellactivation-1400.webp 1400w," sizes="95vw" type="image/webp"></source> <img src="/assets/img/tgn1412/tcellactivation.jpg" class="img-fluid rounded z-depth-1" width="750" height="auto" loading="lazy" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> <figure slot="second"> <picture> <source class="responsive-img-srcset" srcset="/assets/img/tgn1412/tregactivation-480.webp 480w,/assets/img/tgn1412/tregactivation-800.webp 800w,/assets/img/tgn1412/tregactivation-1400.webp 1400w," sizes="95vw" type="image/webp"></source> <img src="/assets/img/tgn1412/tregactivation.jpg" class="img-fluid rounded z-depth-1" width="750" height="auto" loading="lazy" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </img-comparison-slider> <div class="caption" style="text-align: center;"> Use the slider function to experience how the Treg story gradually dominated and deviated the basic understanding of T cell biology, culminating in the catastrophic TGN1412 trial. </div> <h3 id="lessons-from-the-first-treg-immunotherapy-trial">Lessons from the First Treg Immunotherapy Trial</h3> <p>Regulatory T cells (Tregs) are suppressor cells by definition. Usual T cells induce immune response when they recognise their target. However, Tregs can suppress immune response. Thus the current theory is that Tregs are a special type of T cells, functioning to maintain immune system balance and prevent autoimmune diseases, where the body attacks its own cells.</p> <p>However, these T cells aren’t as unique as people believe. This is illustrated in the catastrophic clinical trial for the world-first clinical trial, TGN1412 <a class="citation" href="#RN58">(Bending &amp; Ono, 2018)</a>.</p> <h4 id="the-clinical-trial">The Clinical Trial</h4> <p>The significance of understanding T cells’ dynamics in vivo is illuminated by the clinical trial of TGN1412 in 2006. TGN1412, a superagonistic anti-CD28 antibody intended to suppress autoimmune reactions, instead caused severe inflammation known as a “cytokine storm” in volunteers.</p> <h4 id="turning-point">Turning Point</h4> <p>TGN1412 is a superagonistic anti-CD28 antibody designed to activate T cells directly, eliminating the need for anti-CD3 antibodies. Initially, it was developed with the goal of activating and restoring the T-cell repertoire in leukaemia patients. However, following promising results from animal studies, TGN1412 was later repurposed as an immunosuppressant. These studies showed that the anti-CD28 stimulation selectively activated regulatory T cells (Tregs) and effectively suppressed immune response.</p> <div class="row"> <div class="col-sm mt-3 mt-md-0 text-center"> <figure> <picture> <source class="responsive-img-srcset" srcset="/assets/img/tgn1412/tgn1412-480.webp 480w,/assets/img/tgn1412/tgn1412-800.webp 800w,/assets/img/tgn1412/tgn1412-1400.webp 1400w," sizes="95vw" type="image/webp"></source> <img src="/assets/img/tgn1412/tgn1412.jpg" class="img-fluid rounded z-depth-1" width="600" height="auto" data-zoomable="" loading="eager" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </div> </div> <div class="caption" style="text-align: center;"> Summary of Research and Development Strategies for TGN1412. </div> <h4 id="investigations-and-reflections">Investigations and Reflections</h4> <p>Investigations into the incident concluded that it was an unfortunate and unforeseeable event due to the different expression dynamics of CD28 between humans and primates, which were used in the pre-clinical stage of the drug development.</p> <p>However, as discussed in Vitetta and Ghetie (2006), <strong>Tregs and non-Tregs may not represent strictly separate lineages</strong>. Therefore, the assumption of specifically activating only a minor population may have been inappropriate.</p> <p>It is worth remembering that the first lecture in T cell biology always begins with T cell receptor signaling and CD28 signaling. Without CD28 signaling, T cells cannot be fully activated, as CD28 signaling is a strong activating signal for all T cells.</p> <div class="row"> <div class="col-sm mt-3 mt-md-0 text-center"> <figure> <picture> <source class="responsive-img-srcset" srcset="/assets/img/tgn1412/tcellactivation-480.webp 480w,/assets/img/tgn1412/tcellactivation-800.webp 800w,/assets/img/tgn1412/tcellactivation-1400.webp 1400w," sizes="95vw" type="image/webp"></source> <img src="/assets/img/tgn1412/tcellactivation" class="img-fluid rounded z-depth-1" width="600" height="auto" data-zoomable="" loading="eager" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </div> </div> <div class="caption" style="text-align: center;"> Adapted from My Lecture Slide for Introducting T-cell Biology. </div> <p>This disaster underscored the importance of understanding the roles and activation mechanisms of T cells in general, not just focusing on Treg cells alone.</p> <h4 id="foxp3-and-the-lieage-perspective">Foxp3 and the Lieage Perspective</h4> <p>Asano <em>et al</em> set the stage for the lineage perspective of Treg by highlighting CD25+CD4+ T cells as a “<em>naturally differentiated, unique T cell subset originating in the thymus</em>.” My other article showed that this perspective was not supported by reproducible evidence at the time.</p> <p>However, the subsequent development in immunology—the discovery of Foxp3—fit well with the stage set by Asano <em>et al</em>. Foxp3, as a transcription factor specifically expressed by CD25+CD4+ T cells, was defined as the lineage-determinant factor of Tregs.</p> <p>It is true that Foxp3 is key in controlling the development and function of suppressive T cells. However, by defining Foxp3 as the lineage factor, we overlook an essential aspect of T cells – their dynamic nature and changing properties.</p> <h4 id="treg-plasticity-or-changing-t-cells">Treg Plasticity or Changing T cells?</h4> <p>Recent studies have highlighted the plasticity of Tregs—that is, their ability to change under certain conditions. For example, during inflammation, Tregs can lose their Foxp3 expression and transform into effector T cells, which actively respond to pathogens. This plasticity is crucial because it demonstrates that Tregs can adapt based on the body’s needs, potentially shifting roles from regulators to attackers.</p> <p>However, by categorizing these changes as Treg <em>plasticity</em>, studies remain trapped and constrained by the lineage perspective. Indeed, many researchers and pharmaceutical companies are pursuing the development of a method to produce ‘stable’ Tregs.</p> <p><strong>What if Foxp3 is inherently a dynamic molecule? Is it an effective approach to pursue the stable Treg as a holy grail?</strong></p> <h4 id="from-stability-to-dynamics">From Stability To Dynamics</h4> <p>Revealing the principles of Foxp3 as a dynamic mechanism could significantly improve our ability to control the T cell system. However, this cannot be achieved if studies remain constrained by the lineage perspective that originated with Asano et al.</p> <p>Studying the dynamic changes in Tregs during immune responses is crucial for a deeper understanding of immune regulation. Innovative tools like the Tocky system, which tracks cell kinetics and activity, are enabling researchers to explore how Tregs and their Foxp3 expression change in real-time. These insights are vital for developing effective immunotherapies.</p> <p>Understanding the dynamics of Foxp3 and Treg activity provides a window into the sophisticated mechanisms of immune regulation. This knowledge is not only fundamental to the field of immunology but also crucial for developing new treatments for immune-related diseases.</p> <p>Investigating Foxp3 as a dynamic molecule and the dynamics of T cells in vivo within a broader context will be a fundamental approach not only for understanding T cell biology but also for developing future immunotherapies.</p> <p>The contents of this article are discussed in detail in <a href="https://academic.oup.com/cei/article/197/1/14/6402549" rel="external nofollow noopener" target="_blank">my paper published in 2019</a> and <a href="https://monotockylab.github.io/projects/2_project/">my blog article “Decoding Foxp3 – From Treg Dogma to T-cell Dynamics”</a>.</p> <div class="row"> <div class="col-sm mt-3 mt-md-0 text-center"> <figure> <picture> <source class="responsive-img-srcset" srcset="/assets/img/tgn1412/newton-480.webp 480w,/assets/img/tgn1412/newton-800.webp 800w,/assets/img/tgn1412/newton-1400.webp 1400w," sizes="95vw" type="image/webp"></source> <img src="/assets/img/tgn1412/newton.jpg" class="img-fluid rounded z-depth-1" width="400" height="auto" data-zoomable="" loading="eager" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </div> </div> <hr> </div> </article> <h2>References</h2> <div class="publications"> <h2 class="bibliography">2018</h2> <ol class="bibliography"><li> <div class="row"> <div class="col-sm-2 abbr"> </div> <div id="RN58" class="col-sm-8"> <div class="title">From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics</div> <div class="author"> David Bending , and <em>Masahiro Ono</em> </div> <div class="periodical"> <em>Clinical and Experimental Immunology</em>, Sep 2018 </div> <div class="periodical"> <em style="color: darkgrey;"></em> </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abstract</a> <a href="https://doi.org/10.1111/cei.13194" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">Publication</a> </div> <div class="abstract hidden"> <p>Studies on regulatory T cells (Treg) have focused on thymic Treg as a stable lineage of immunosuppressive T cells, the differentiation of which is controlled by the transcription factor forkhead box protein 3 (Foxp3). This lineage perspective, however, may constrain hypotheses regarding the role of Foxp3 and Treg  in vivo, particularly in clinical settings and immunotherapy development. In this review, we synthesize a new perspective on the role of Foxp3 as a dynamically expressed gene, and thereby revisit the molecular mechanisms for the transcriptional regulation of Foxp3. In particular, we introduce a recent advancement in the study of Foxp3-mediated T cell regulation through the development of the Timer of cell kinetics and activity (Tocky) system, and show that the investigation of Foxp3 transcriptional dynamics can reveal temporal changes in the differentiation and function of Treg  in vivo. We highlight the role of Foxp3 as a gene downstream of T cell receptor (TCR) signalling and show that temporally persistent TCR signals initiate Foxp3 transcription in self-reactive thymocytes. In addition, we feature the autoregulatory transcriptional circuit for the Foxp3 gene as a mechanism for consolidating Treg differentiation and activating their suppressive functions. Furthermore, we explore the potential mechanisms behind the dynamic regulation of epigenetic modifications and chromatin architecture for Foxp3 transcription. Lastly, we discuss the clinical relevance of temporal changes in the differentiation and activation of Treg.</p> </div> </div> </div> </li></ol> </div> <br> <hr> <br> <ul class="list-disc pl-8"></ul> <h2 class="text-3xl font-semibold mb-4 mt-12">Enjoy Reading This Article?</h2> <p class="mb-2">Here are some more articles you might like to read next:</p> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/CD25/">The Unsung Roles of HTLV-1 in the Discovery of CD25 and Treg</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/CancerImmunotherapy/">tocky illuminates mechanisms of immune checkpoint blockade</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/dermatology/">professionalism and official account integrity</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/timer/">timer and tocky</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/reflections/">reflections on my research history</a> </li> </div> </div> <footer class="fixed-bottom" role="contentinfo"> <div class="container mt-0"> © Copyright 2024 Masahiro Ono. Powered by <a href="https://jekyllrb.com/" target="_blank" rel="external nofollow noopener">Jekyll</a> with <a href="https://github.com/alshedivat/al-folio" rel="external nofollow noopener" target="_blank">al-folio</a> theme. Hosted by <a href="https://pages.github.com/" target="_blank" rel="external nofollow noopener">GitHub Pages</a>. Last updated: November 15, 2024. </div> </footer> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.0/dist/jquery.min.js" integrity="sha256-/xUj+3OJU5yExlq6GSYGSHk7tPXikynS7ogEvDej/m4=" crossorigin="anonymous"></script> <script src="/assets/js/bootstrap.bundle.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/js/mdb.min.js" integrity="sha256-NdbiivsvWt7VYCt6hYNT3h/th9vSTL4EDWeGs5SN3DA=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/masonry-layout@4.2.2/dist/masonry.pkgd.min.js" integrity="sha256-Nn1q/fx0H7SNLZMQ5Hw5JLaTRZp0yILA/FRexe19VdI=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/imagesloaded@5.0.0/imagesloaded.pkgd.min.js" integrity="sha256-htrLFfZJ6v5udOG+3kNLINIKh2gvoKqwEhHYfTTMICc=" crossorigin="anonymous"></script> <script defer src="/assets/js/masonry.js" type="text/javascript"></script> <script defer src="https://cdn.jsdelivr.net/npm/medium-zoom@1.1.0/dist/medium-zoom.min.js" integrity="sha256-ZgMyDAIYDYGxbcpJcfUnYwNevG/xi9OHKaR/8GK+jWc=" crossorigin="anonymous"></script> <script defer src="/assets/js/zoom.js?85ddb88934d28b74e78031fd54cf8308"></script> <script src="/assets/js/no_defer.js?5d75c11f89cd96294bf5e6dd1ee1bb30"></script> <script defer src="/assets/js/common.js?fcfacfb8c6281f5e68d5a7d348186eb1"></script> <script defer src="/assets/js/copy_code.js?12775fdf7f95e901d7119054556e495f" type="text/javascript"></script> <script defer src="/assets/js/jupyter_new_tab.js?d9f17b6adc2311cbabd747f4538bb15f"></script> <script async src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script async src="https://badge.dimensions.ai/badge.js"></script> <script type="text/javascript">window.MathJax={tex:{tags:"ams"}};</script> <script defer type="text/javascript" id="MathJax-script" src="https://cdn.jsdelivr.net/npm/mathjax@3.2.0/es5/tex-mml-chtml.js"></script> <script defer src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6"></script> <script async src="https://www.googletagmanager.com/gtag/js?id=G-VJHT0Y5RYF"></script> <script>function gtag(){window.dataLayer.push(arguments)}window.dataLayer=window.dataLayer||[],gtag("js",new Date),gtag("config","G-VJHT0Y5RYF");</script> <script type="text/javascript">function progressBarSetup(){"max"in document.createElement("progress")?(initializeProgressElement(),$(document).on("scroll",function(){progressBar.attr({value:getCurrentScrollPosition()})}),$(window).on("resize",initializeProgressElement)):(resizeProgressBar(),$(document).on("scroll",resizeProgressBar),$(window).on("resize",resizeProgressBar))}function getCurrentScrollPosition(){return $(window).scrollTop()}function initializeProgressElement(){let e=$("#navbar").outerHeight(!0);$("body").css({"padding-top":e}),$("progress-container").css({"padding-top":e}),progressBar.css({top:e}),progressBar.attr({max:getDistanceToScroll(),value:getCurrentScrollPosition()})}function getDistanceToScroll(){return $(document).height()-$(window).height()}function resizeProgressBar(){progressBar.css({width:getWidthPercentage()+"%"})}function getWidthPercentage(){return getCurrentScrollPosition()/getDistanceToScroll()*100}const progressBar=$("#progress");window.onload=function(){setTimeout(progressBarSetup,50)};</script> <script defer src="https://cdn.jsdelivr.net/npm/img-comparison-slider@8.0.6/dist/index.min.js"></script> <script defer src="https://cdn.jsdelivr.net/npm/swiper@11.0.5/swiper-element-bundle.min.js" integrity="sha256-BPrwikijIybg9OQC5SYFFqhBjERYOn97tCureFgYH1E=" crossorigin="anonymous"></script> </body> </html>